#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	11776	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2208	528.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1470	1470	C	694	C	677	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21760	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3604	600.8	0	.	n	.	0	T695C	SNP	695	695	T	1094	1094	C	608	C,T	599,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21760	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3604	600.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1736	1736	A	746	A,G	734,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21760	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3604	600.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2370	2370	C	653	C	638	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21760	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3604	600.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2444	2444	A	650	A	632	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21760	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3604	600.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2996	2996	C	634	C	616	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1572	folP	852	852	100.0	folP.l15.c4.ctg.1	1614	97.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1068	1070	AGC	155;153;154	A;G;C	152;153;152	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4614	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	135.5	1	SNP	p	S91F	0	.	.	271	273	TCC	641	643	TCC	156;158;160	T;C;C	154;156;158	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4614	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	135.5	1	SNP	p	D95G	0	.	.	283	285	GAC	653	655	GAC	163;163;162	G;A;C	159;159;158	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4614	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3388	135.5	1	SNP	p	D95N	0	.	.	283	285	GAC	653	655	GAC	163;163;162	G;A;C	159;159;158	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1422	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1389	102.1	1	SNP	p	G45D	1	.	.	133	135	GAC	483	485	GAC	176;173;173	G;A;C	172;168;172	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	808	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1016	79.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3928	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	133.1	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	141;143;144	G;A;C	140;137;142	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3928	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	133.1	1	SNP	p	S87W	0	.	.	259	261	AGT	577	579	AGT	141;138;139	A;G;T	138;136;134	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3928	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	133.1	1	SNP	p	S87I	0	.	.	259	261	AGT	577	579	AGT	141;138;139	A;G;T	138;136;134	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3928	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	133.1	1	SNP	p	S87R	0	.	.	259	261	AGT	577	579	AGT	141;138;139	A;G;T	138;136;134	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	3928	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2932	133.1	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	139;139;140	T;C;C	133;134;137	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3510	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2695	129.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1544	1546	GGC	167;166;166	G;G;C	162;163;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1260	1262	GCA	157;160;162	G;C;A	154;156;160	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1263	1265	ATC	161;160;157	A;T;C	160;159;154	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1275	1277	GTG	152;149;151	G;T;G	151;144;150	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1275	1277	GTG	152;149;151	G;T;G	151;144;150	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1779	1781	ACC	139;139;137	A;C;C	135;136;134	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1833	1835	GCG	121;123;122	G;C,G;G	115;105,1;115	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1833	1835	GCG	121;123;122	G;C,G;G	115;105,1;115	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1956	1958	GGC	102;99;99	G;G;C	97;95;93	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1965	1967	GGC	98;96;97	G;G;C	92;90;90	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	2894	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2484	115.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1983	1985	CCG	71;73;73	C;C;G	67;67;64	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4750	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3152	149.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1602	1604	CTG	164;164;164	C;T;G	160;156;157	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	910	porA	1188	1188	91.21	porA.l15.c30.ctg.1	1666	54.2	0	.	p	.	0	R34N	NONSYN	100	102	AGG	458	460	AAC	46;46;46	A;A,G;C,G	43;43,1;43,1	.	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	910	porA	1188	1188	91.21	porA.l15.c30.ctg.1	1666	54.2	0	.	p	.	0	A38L	NONSYN	112	114	GCG	470	472	CTG	49;48;48	C;T;G	49;47;46	.	.
porA.WHO_U_01087c	porA.WHO_U_01087c	1	0	539	910	porA	1188	1188	91.21	porA.l15.c30.ctg.1	1666	54.2	0	.	p	.	0	E42fs	FSHIFT	124	124	G	482	482	G	54	G	52	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	0	.	p	.	0	E38G	NONSYN	112	114	GAA	396	398	GGA	194;186;185	G;G,A;A	191;182,1;181	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	0	.	p	.	0	V45I	NONSYN	133	135	GTT	417	419	ATT	182;182;183	A;T;T	178;178;179	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	915	915	T	200	T,A	189,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	1	SNP	p	G120K	0	.	.	358	360	GGT	642	644	GGT	168;169;170	G;G;T,G	163;167;160,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	1	SNP	p	A121N	0	.	.	361	363	GCC	645	647	GCC	169;166;166	G,A;C;C,G	161,1;158;163,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2280	porB1b	1035	1035	98.38	porB1b.l15.c17.ctg.1	1469	153.6	1	SNP	p	A121D	0	.	.	361	363	GCC	645	647	GCC	169;166;166	G,A;C;C,G	161,1;158;163,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7510	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4915	152.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1923	1925	AAT	178;179;180	A;A;T	177;174;177	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	886	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1135	77.7	1	SNP	p	V57M	1	.	.	169	171	ATG	552	554	ATG	162;162;160	A;T;G	160;158;155	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
